Cargando…

Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum

Background: Of all readmissions, 21% are medication-related readmissions (MRRs). However, it is unknown whether MRRs are recognized at the time of readmission and are communicated in the care continuum. Objectives: To identify the prevalence of MRRs that contain a documentation on the medication inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ze-Yun, Uitvlugt, Elien B., Karapinar-Çarkit, Fatma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978797/
https://www.ncbi.nlm.nih.gov/pubmed/35387329
http://dx.doi.org/10.3389/fphar.2022.824892
_version_ 1784681033446195200
author Lee, Ze-Yun
Uitvlugt, Elien B.
Karapinar-Çarkit, Fatma
author_facet Lee, Ze-Yun
Uitvlugt, Elien B.
Karapinar-Çarkit, Fatma
author_sort Lee, Ze-Yun
collection PubMed
description Background: Of all readmissions, 21% are medication-related readmissions (MRRs). However, it is unknown whether MRRs are recognized at the time of readmission and are communicated in the care continuum. Objectives: To identify the prevalence of MRRs that contain a documentation on the medication involved (and therefore are regarded as recognized), and the proportion of communicated MRRs. Setting: The study was performed in a teaching hospital. Methods: In a previous study, a multidisciplinary team of physicians and pharmacists assessed the medication-relatedness, the medication involved and preventability of unplanned readmissions from seven departments. In the current cross-sectional study, two pharmacy team members evaluated the patient records independently. An MRR was regarded as recognized when the medication involved was documented in patient records. An MRR was regarded as communicated to the patient and/or the next healthcare provider when the medication involved or a description was mentioned in discharge letters or discharge prescriptions. The relationship between documented MRRs and whether the MRR was preventable as well as the relationship between (un)documented MRRs and the length of stay (LOS) were assessed. Descriptive data analysis was used. Results: Of 181 included MRRs, 72 (40%) were deemed preventable by the multidisciplinary team. For 159 of 181 MRRs (88%), a documentation on the medication involved was present. Of 159 documented MRRs, 93 (58%) were communicated to patients and/or caregivers, 137 (86%) to the general practitioner, and 4 (3%) to the community pharmacy. The medication involved was documented less often for potentially preventable MRRs than for non-preventable MRRs (78 vs. 95%; p = 0.002). The LOS was longer for MRRs where the medication involved was undocumented (median 8 vs. 5 days; p = 0.062). Conclusion: The results of this study imply that MRRs are not always recognized, which could impact patients’ well-being. In this study an increased LOS was observed with unrecognized MRRs. Communication of MRRs to the patients and/or the next healthcare providers should be improved.
format Online
Article
Text
id pubmed-8978797
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89787972022-04-05 Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum Lee, Ze-Yun Uitvlugt, Elien B. Karapinar-Çarkit, Fatma Front Pharmacol Pharmacology Background: Of all readmissions, 21% are medication-related readmissions (MRRs). However, it is unknown whether MRRs are recognized at the time of readmission and are communicated in the care continuum. Objectives: To identify the prevalence of MRRs that contain a documentation on the medication involved (and therefore are regarded as recognized), and the proportion of communicated MRRs. Setting: The study was performed in a teaching hospital. Methods: In a previous study, a multidisciplinary team of physicians and pharmacists assessed the medication-relatedness, the medication involved and preventability of unplanned readmissions from seven departments. In the current cross-sectional study, two pharmacy team members evaluated the patient records independently. An MRR was regarded as recognized when the medication involved was documented in patient records. An MRR was regarded as communicated to the patient and/or the next healthcare provider when the medication involved or a description was mentioned in discharge letters or discharge prescriptions. The relationship between documented MRRs and whether the MRR was preventable as well as the relationship between (un)documented MRRs and the length of stay (LOS) were assessed. Descriptive data analysis was used. Results: Of 181 included MRRs, 72 (40%) were deemed preventable by the multidisciplinary team. For 159 of 181 MRRs (88%), a documentation on the medication involved was present. Of 159 documented MRRs, 93 (58%) were communicated to patients and/or caregivers, 137 (86%) to the general practitioner, and 4 (3%) to the community pharmacy. The medication involved was documented less often for potentially preventable MRRs than for non-preventable MRRs (78 vs. 95%; p = 0.002). The LOS was longer for MRRs where the medication involved was undocumented (median 8 vs. 5 days; p = 0.062). Conclusion: The results of this study imply that MRRs are not always recognized, which could impact patients’ well-being. In this study an increased LOS was observed with unrecognized MRRs. Communication of MRRs to the patients and/or the next healthcare providers should be improved. Frontiers Media S.A. 2022-03-21 /pmc/articles/PMC8978797/ /pubmed/35387329 http://dx.doi.org/10.3389/fphar.2022.824892 Text en Copyright © 2022 Lee, Uitvlugt and Karapinar-Çarkit. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lee, Ze-Yun
Uitvlugt, Elien B.
Karapinar-Çarkit, Fatma
Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum
title Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum
title_full Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum
title_fullStr Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum
title_full_unstemmed Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum
title_short Medication-Related Readmissions: Documentation of the Medication Involved and Communication in the Care Continuum
title_sort medication-related readmissions: documentation of the medication involved and communication in the care continuum
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978797/
https://www.ncbi.nlm.nih.gov/pubmed/35387329
http://dx.doi.org/10.3389/fphar.2022.824892
work_keys_str_mv AT leezeyun medicationrelatedreadmissionsdocumentationofthemedicationinvolvedandcommunicationinthecarecontinuum
AT uitvlugtelienb medicationrelatedreadmissionsdocumentationofthemedicationinvolvedandcommunicationinthecarecontinuum
AT karapinarcarkitfatma medicationrelatedreadmissionsdocumentationofthemedicationinvolvedandcommunicationinthecarecontinuum